← Evidence map

ArticleTherapeutic advances in urology2015

Efficacy of triptorelin pamoate 11.25 mg administered subcutaneously for achieving medical castration levels of testosterone in patients with locally advanced or metastatic prostate cancer.

Thiery Lebret et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2015
2016
2017
2018
2019
2020
2021
2022
2023
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 26161143